CompletedNCT00081380
Quetiapine added to lithium or divalproex for ongoing care in bipolarity
About this title
Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
Read the official source — NCT00081380Medication studyAges 18+United States + Canada
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- Birmingham and 93 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMarch 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 710
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT00081380
- Official title
Show the full official title
Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo as Adjunct to Mood Stabilizers (Lithium or Divalproex) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham, United States · Scottsdale, United States · Little Rock, United States
91 more locations
- Anaheim, United States
- Cerritos, United States
- Chula Vista, United States
- Culver City, United States
- Garden Grove, United States
- La Mesa, United States
- Oceanside, United States
- Orange, United States
- Pico Rivera, United States
- Riverside, United States
- Rosemead, United States
- San Diego, United States
- San Francisco, United States
- Santa Ana, United States
- Farmington, United States
- New Britain, United States
- Jacksonville, United States
- Miami, United States
- Orlando, United States
- West Palm Beach, United States
- Winter Park, United States
- Atlanta, United States
- Decatur, United States
- Marietta, United States
- Smyrna, United States
- Honolulu, United States
- Chicago, United States
- Hoffman Estates, United States
- Joliet, United States
- Evansville, United States
- Greenwood, United States
- Indianapolis, United States
- Wichita, United States
- Florence, United States
- Lake Charles, United States
- New Orleans, United States
- Shreveport, United States
- Baltimore, United States
- Rockville, United States
- Pittsfield, United States
- New Baltimore, United States
- St Louis, United States
- Clementon, United States
- Moorestown, United States
- West Caldwell, United States
- Albuquerque, United States
- Brooklyn, United States
- New York, United States
- The Bronx, United States
- Butner, United States
- Raleigh, United States
- Beachwood, United States
- Cincinnati, United States
- Dayton, United States
- Medina, United States
- Oklahoma City, United States
- Tulsa, United States
- Eugene, United States
- Portland, United States
- Emmaus, United States
- Moon Township, United States
- Philadelphia, United States
- Charleston, United States
- Memphis, United States
- Austin, United States
- Dallas, United States
- DeSoto, United States
- Houston, United States
- Irving, United States
- San Antonio, United States
- Wichita Falls, United States
- Charlottesville, United States
- Falls Church, United States
- Richmond, United States
- Virginia Beach, United States
- Bellevue, United States
- Kirkland, United States
- Morgantown, United States
- Edmonton, Canada
- Vancouver, Canada
- Victoria, Canada
- Winnipeg, Canada
- Halifax, Canada
- Hamilton, Canada
- Kingston, Canada
- Markham, Canada
- Mississauga, Canada
- Oshawa, Canada
- Toronto, Canada
- Montreal, Canada
- Québec, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Did this study involve medication?
Yes. The study involved medication, including Seroquel®, quetiapine fumarate (atypical antipsychotic), lithium (mood stabilizer) and divalproex (mood stabilizer).
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
